Location History:
- Sunnyvale, CA (US) (1989)
- Lincoln, NE (US) (1990 - 1991)
- Easton, CT (US) (1993 - 1994)
- Waverly, NE (US) (1994 - 1998)
- Los Altos, CA (US) (2001)
- El Cerrito, CA (US) (2006 - 2021)
Company Filing History:
3 out of 780 
2 out of 1,384 
1 out of 7 Years Active: 1989-2021
Title: Richard L. Feldman: Innovator in Hematology
Introduction
Richard L. Feldman, based in Lincoln, Nebraska, is a distinguished inventor with a significant contribution to the field of hematology. With a total of 14 patents to his name, Feldman has dedicated his career to developing innovative solutions for treating hematological diseases, particularly hemophilia A.
Latest Patents
Feldman’s latest patents focus on targeted coagulation factors that are designed to enhance the treatment of hemophilia A. One notable patent is the "Red blood cell targeted factor VIII and method of using the same," which details targeted Factor VIII molecules that are linked with domains specifically binding to membrane proteins on red blood cells. This innovation improves the duration of action of coagulation factors, thereby offering advancements in the management of hematological conditions.
Another significant patent is the "Targeted coagulation factors and method of using the same," which reveals a composition of coagulation factors linked with domains that attach to blood cell membrane proteins. This development not only increases the efficacy of these factors but also prolongs their action, representing a remarkable step forward in treating hemophilia A and similar disorders.
Career Highlights
Richard L. Feldman has worked for notable organizations such as Bayer Healthcare LLC, where he further developed his expertise and contributed to groundbreaking innovations in medical treatments. His experience in such a prominent company underscores his commitment to advancing healthcare through innovative solutions.
Collaborations
Throughout his career, Feldman has collaborated with talented individuals, including Judi Bryant and Monica J. Kochanny. These collaborations have likely fostered an environment of creativity and innovation, helping to bring his inventive concepts to fruition.
Conclusion
In summary, Richard L. Feldman is a pioneering inventor in the field of hematology, with a track record of significant patents aimed at improving the treatment of hemophilia A. His innovative work and collaborations highlight his dedication to enhancing patient care and advancing medical science. As he continues to make strides in his field, his contributions will undoubtedly leave a lasting impact on the treatment landscape for hematological diseases.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.